Thomas P J Solomon1, Steven K Malin2, Kristian Karstoft3, Sine H Knudsen3, Jacob M Haus4, Matthew J Laye3, John P Kirwan5. 1. Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark Centre of Inflammation and Metabolism and Centre for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark thomas.solomon@sund.ku.dk. 2. Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. 3. Centre of Inflammation and Metabolism and Centre for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark. 4. Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL. 5. Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH Metabolic Translational Research Center, Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH.
Abstract
OBJECTIVE: Cardiorespiratory fitness (VO2max) is associated with glycemic control, yet the relationship between VO2max and the underlying determinants of glycemic control is less clear. Our aim was to determine whether VO2max is associated with insulin sensitivity, insulin secretion, and the disposition index, a measure of compensatory pancreatic β-cell insulin secretion relative to insulin sensitivity, in subjects representing the entire range of the glucose tolerance continuum. RESEARCH DESIGN AND METHODS: A cohort of subjects (N = 313) with heterogeneous age, sex, BMI, and glycemic control underwent measurements of body composition, HbA1c, fasting glucose, oral glucose tolerance (OGTT), and VO2max. OGTT-derived insulin sensitivity (SiOGTT), glucose-stimulated insulin secretion (GSISOGTT), and the disposition index (DIOGTT) (the product of SiOGTT and GSISOGTT) were measured, and associations between VO2max and these determinants of glycemic control were examined. RESULTS: A low VO2max was associated with high HbA1c (r = -0.33), high fasting glucose (r = -0.34), high 2-h OGTT glucose (r = -0.33), low SiOGTT (r = 0.73), and high early-phase (r = -0.34) and late-phase (r = -0.36) GSISOGTT. Furthermore, a low VO2max was associated with low early- and late-phase DIOGTT (both r = 0.41). Interestingly, relationships between VO2max and either glycemic control or late-phase GSISOGTT deteriorated across the glucose tolerance continuum. CONCLUSIONS: The association between poor cardiorespiratory fitness and compromised pancreatic β-cell compensation across the entire glucose tolerance continuum provides additional evidence highlighting the importance of fitness in protection against the onset of a fundamental pathophysiological event that leads to type 2 diabetes.
OBJECTIVE:Cardiorespiratory fitness (VO2max) is associated with glycemic control, yet the relationship between VO2max and the underlying determinants of glycemic control is less clear. Our aim was to determine whether VO2max is associated with insulin sensitivity, insulin secretion, and the disposition index, a measure of compensatory pancreatic β-cell insulin secretion relative to insulin sensitivity, in subjects representing the entire range of the glucose tolerance continuum. RESEARCH DESIGN AND METHODS: A cohort of subjects (N = 313) with heterogeneous age, sex, BMI, and glycemic control underwent measurements of body composition, HbA1c, fasting glucose, oral glucose tolerance (OGTT), and VO2max. OGTT-derived insulin sensitivity (SiOGTT), glucose-stimulated insulin secretion (GSISOGTT), and the disposition index (DIOGTT) (the product of SiOGTT and GSISOGTT) were measured, and associations between VO2max and these determinants of glycemic control were examined. RESULTS: A low VO2max was associated with high HbA1c (r = -0.33), high fasting glucose (r = -0.34), high 2-h OGTT glucose (r = -0.33), low SiOGTT (r = 0.73), and high early-phase (r = -0.34) and late-phase (r = -0.36) GSISOGTT. Furthermore, a low VO2max was associated with low early- and late-phase DIOGTT (both r = 0.41). Interestingly, relationships between VO2max and either glycemic control or late-phase GSISOGTT deteriorated across the glucose tolerance continuum. CONCLUSIONS: The association between poor cardiorespiratory fitness and compromised pancreatic β-cell compensation across the entire glucose tolerance continuum provides additional evidence highlighting the importance of fitness in protection against the onset of a fundamental pathophysiological event that leads to type 2 diabetes.
Authors: Normand G Boulé; S John Weisnagel; Timo A Lakka; Angelo Tremblay; Richard N Bergman; Tuomo Rankinen; Arthur S Leon; James S Skinner; Jack H Wilmore; D C Rao; Claude Bouchard Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Claus Thamer; Michael Stumvoll; Andreas Niess; Otto Tschritter; Michael Haap; Regine Becker; Fatemeh Shirkavand; Oliver Bachmann; Kristian Rett; Annette Volk; Hans Häring; Andreas Fritsche Journal: Diabetes Care Date: 2003-07 Impact factor: 19.112
Authors: Flemming Dela; Michael E von Linstow; Kári Joensen Mikines; Henrik Galbo Journal: Am J Physiol Endocrinol Metab Date: 2004-07-13 Impact factor: 4.310
Authors: M Krotkiewski; P Lönnroth; K Mandroukas; Z Wroblewski; M Rebuffé-Scrive; G Holm; U Smith; P Björntorp Journal: Diabetologia Date: 1985-12 Impact factor: 10.122
Authors: Adam Hulman; Rebecca K Simmons; Dorte Vistisen; Adam G Tabák; Jacqueline M Dekker; Marjan Alssema; Femke Rutters; Anitra D M Koopman; Thomas P J Solomon; John P Kirwan; Torben Hansen; Anna Jonsson; Anette Prior Gjesing; Hans Eiberg; Arne Astrup; Oluf Pedersen; Thorkild I A Sørensen; Daniel R Witte; Kristine Færch Journal: Endocrine Date: 2016-10-03 Impact factor: 3.633
Authors: Joyce S Ramos; Lance C Dalleck; Fabio Borrani; Alistair R Mallard; Bronwyn Clark; Shelley E Keating; Robert G Fassett; Jeff S Coombes Journal: Diabetologia Date: 2016-08-01 Impact factor: 10.122
Authors: Edwin R Miranda; Vikram S Somal; Jacob T Mey; Brian K Blackburn; Edward Wang; Sarah Farabi; Kristian Karstoft; Ciaran E Fealy; Sangeeta Kashyap; John P Kirwan; Laurie Quinn; Thomas P J Solomon; Jacob M Haus Journal: Am J Physiol Endocrinol Metab Date: 2017-08-15 Impact factor: 4.310
Authors: Tara L MacDonald; Pattarawan Pattamaprapanont; Prerana Pathak; Natalie Fernandez; Ellen C Freitas; Samar Hafida; Joanna Mitri; Steven L Britton; Lauren G Koch; Sarah J Lessard Journal: Nat Metab Date: 2020-07-20
Authors: Lærke P Lidegaard; Anne-Louise S Hansen; Nanna B Johansen; Daniel R Witte; Søren Brage; Torsten Lauritzen; Marit E Jørgensen; Dirk L Christensen; Kristine Færch Journal: Diabetologia Date: 2015-09-05 Impact factor: 10.122